Scientists from the Gladstone Institute of Virology and Immunology and the National Institutes of Allergy and Infectious Diseases have identified a gene that may influence the production of antibodies that neutralize HIV. This new information will likely spur a new approach for making an HIV vaccine that elicits neutralizing antibodies.
